Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 15, 2019 - Issue 3
Submit an article Journal homepage
1,897
Views
5
CrossRef citations to date
0
Altmetric
Research Paper

Persistence of antibodies 1 year after sequential administration of the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine in adults

Beate Schmoele-ThomaPfizer Vaccine Clinical Research and Development, Pfizer Pharma GmbH, Berlin, GermanyCorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0003-4632-357XView further author information
ORCID Icon,
Martin van CleeffTriangle Medical Research Associates, Raleigh, NC, USAView further author information
,
Richard N. GreenbergPfizer Vaccine Clinical Research and Development, Pearl River, NY, USAView further author information
,
Alejandra GurtmanPfizer Vaccines Research, Pearl River, NY, USAView further author information
,
Thomas R. JonesPfizer Vaccines Research, Pearl River, NY, USAView further author information
,
Vani SundaraiyerSyneos Health, Princeton, NJ, USAView further author information
,
William C. GruberPfizer Vaccines Research, Pearl River, NY, USAView further author information
&
Daniel A. ScottPfizer Vaccines Research, Pearl River, NY, USAView further author information
 show all
Pages 575-583 | Received 06 Feb 2018, Accepted 13 Oct 2018, Published online: 16 Jan 2019

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Allan W. Cripps, Temitope Folaranmi, Kelly D. Johnson, Luwy Musey, Michael S. Niederman & Ulrike K. Buchwald. (2021) Immunogenicity following revaccination or sequential vaccination with 23-valent pneumococcal polysaccharide vaccine (PPSV23) in older adults and those at increased risk of pneumococcal disease: a review of the literature. Expert Review of Vaccines 20:3, pages 257-267.
Read now
Mario Rivera-Izquierdo, Maria del Carmen Valero-Ubierna, Pelayo Nieto-Gómez, María Dolores Martínez-Bellón, Nicolás Francisco Fernández-Martínez & José Luis Barranco-Quintana. (2020) Vaccination in patients under monoclonal antibody treatment: an updated comprehensive review. Expert Review of Vaccines 19:8, pages 727-744.
Read now

Articles from other publishers (3)

Marina Ulanova, Brenda Huska, Sacha Dubois & William McCready. (2022) Opsonophagocytic activity against Streptococcus pneumoniae in Indigenous and non-Indigenous patients with severe chronic kidney disease immunized with 13-valent pneumococcal conjugate vaccine. Vaccine 40:32, pages 4594-4602.
Crossref
Xiaobai Zou, Jianmei He, Jun Zheng, Mengran Liang, Jinjin Gao, Jianwen Huang, Yang Jiang, Yonglin Jiang & Xi Chen. (2022) Evaluation of effectiveness, safety and cost-benefit of the 23– valent pneumococcal capsular polysaccharide vaccine for HIV-Infected patients. Vaccine 40:1, pages 37-42.
Crossref
Kevin Cannon, Charles Elder, Mariano Young, Daniel A. Scott, Ingrid L. Scully, Gary Baugher, Yahong Peng, Kathrin U. Jansen, William C. Gruber & Wendy Watson. (2021) A trial to evaluate the safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine in populations of adults ≥65 years of age with different prior pneumococcal vaccination. Vaccine 39:51, pages 7494-7502.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.